View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 23, 2020

Beyond testing: importance of antibody-based drugs against Covid-19

By Allie Nawrat

Antibody tests have been heralded as a crucial weapon in the battle against the Covid-19 pandemic. Although these tests are essential to helping epidemiologists better understand the disease and how it spreads, the precise antibodies developed against Covid-19 are also invaluable in discovering therapies to treat patients.

Berkeley Lights CEO Eric Hobbs notes it is going to take a while for vaccines to be approved, but “in the meantime, there is something that will help [tackle Covid-19]: antibody therapeutics.” Hobbs discusses how his company’s Beacon platform can support the development of these drugs against Covid-19, as well as future emerging pathogens.

Read the full story here.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy